Category: Big Pharma
-
Fauci and Pfizer are After Young Children, Hoping FDA to Authorize Pfizer COVID Jab for Two to Four-Year-Olds
In a January 19, 2022 article published in CNBC, Spencer Kimball reported that Dr. Anthony Fauci has high hopes that US Food and Drug Administration will authorize Pfizer’s COVID injection for kids under 5 in the next month. According to the report, White House chief medical advisor Dr. Anthony Fauci said younger children would likely…
-
CDC Endorses Pfizer, Moderna Vaccines Over J&J, Citing Blood Clot Risk — But Data Show All Three Carry Similar Risk
In a December 17, 2021 article for The Defender, Megan Redshaw reported, that an advisory panel to the Centers for Disease Control and Prevention (CDC) on Thursday voted to “preferentially recommend” mRNA COVID vaccines Pfizer and Moderna over the Johnson & Johnson (J&J) shot for adults 18 years and older. According to the report, the recommendation came…
-
Why Isn’t the Pfizer Vaccine Approved in China if it is the Most “Efficacious” of All COVID Vaccines?
In a December 15, 2021 article published in NZ Herald, Alex Blair reported that China’s failure to approve the use of the Pfizer/BioNTech vaccine is a political issue, not an economic or biological one. The report follows the story of a Chinese billionaire, Guo Guangchang, owner of Fosun Pharma. Guangchang signed a NZ$207 million contract…
-
Covid-19 Vaccine Trials Adverse Events are Under-Reported
In a November 24, 2021 article published in Investigative Journalism, Maryanne Demasi, Ph.D., analyzed underreporting of COVID-19 vaccine trial adverse events. According to Demasi, Phase III controlled trials are considered the ‘gold standard’ for assessing vaccine efficacy and safety in humans. In the Pfizer and AstraZeneca vaccine trials, participants were given digital apps to record adverse…
-
Pfizer-BioNTech Continue Their Lies: Claim Booster Doses Will Protect Against Omicron
In a December 8, 2021 article published in CNBC, Spencer Kimball reported that Pfizer and BioNTech executives say booster dose provides a high level of protection against omicron variant in an initial lab study. Pfizer CEO Albert Bourla said in a joint statement with BioNTech said: “Although two doses of the vaccine may still offer…
-
The Deep Entanglement of Big Tech, Media, and Pfizer
The following two articles published by The National Pulse, discuss the conflict of interest and revolving door involving Big Tech, Multi-Media News Provider [including mainstream media], and Pfizer. In a December 1, 2021 article, Kay Smythe reported that the Chairman and former Chief Executive Officer (CEO) of the Reuters news agency – James C. Smith…
-
BioNTech CEO Tries to Sell Boosters, Ignores Reality that Omicron is Non-Lethal
In this December 8, 2021 article published in The National Files, Jack Hadfield reports on the statements of Ugur Sahin, the CEO of BioNTech regarding the efficacy of his company’s COVID vaccine versus the Omicron variant. Sahin said: “Our preliminary, first dataset indicates that a third dose could still offer a sufficient level of protection…
-
Pfizer’s Assassin Vaccine
By Nicanor Perlas 09 December 2021 Pfizer’s “vaccine” is not a vaccine. It is a medical device meant to turn your entire body into a permanent facility for manufacturing spike proteins, as Bill Gates once blogged with glee[efn_note]https://www.gatesnotes.com/Health/Innovation-for-COVID[/efn_note]. Unfortunately, in itself, these spike proteins are toxic and can also harm and cause deaths on their…
-
Evidence Shows: Taking Booster Shot is Insanity
In the December 2, 2021 article published in The Expose, Rhoda Wilson had analyzed various reports and came out with the conclusion that governments claimed the solution to Covid is more Covid injections as people are being encouraged to get a “booster.” According to Wilson, covid jabs’ efficacy wanes after a few months, with six months…
-
Vaccine Efficacy: Pfizer and Moderna CEOs Have Differing Claims
This article delves into two write-ups featuring the two CEOs from two vaccine companies, each with differing opinions regarding vaccine efficacy. In a November 30, 2021 article published in Financial Times, Stephane Bancel, chief executive of Moderna, predicted that existing covid jabs will be much less effective at tackling Omicron compared to earlier coronavirus variants.…
